Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Sommariva

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Recenti Progressi in Medicina|October 1, 1982
[The problem of atherogenesis. Relationship to intracellular metabolism of cholesterol]D Sommariva, D Bonfiglioli
International Journal of Clinical Pharmacology Research|January 1, 1995
Effect of bezafibrate on HDL with APO A-I and APO A-II and on HDL with APO A-I without APO A-II in hyperlipidaemic patientsA Branchi, A Rovellini, D Sommariva
Atherosclerosis|January 1, 1978
Low-fat diet versus low-carbohydrate diet in the treatment of type IV hyperlipoproteinaemiaD Sommariva, L Scotti, A Fasoli
International Journal of Clinical & Laboratory Research|February 24, 2001
Serum lipoprotein profile in patients with cancer. A comparison with non-cancer subjectsA M Fiorenza, A Branchi, D Sommariva
Drugs Under Experimental and Clinical Research|January 1, 1986
Effects of benfluorex on sterol biosynthesis in incubated human blood mononuclear cellsD Sommariva, F Blasi, R Cosentini, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|March 1, 1981
Effects of acetylsalicylic acid on plasma lipids and on post-heparin lipase activitiesD Sommariva, D Bonfiglioli, L Zanaboni, et al.
La Clinica Terapeutica|June 30, 1983
[Effects of nicotinic alcohol therapy on serum lipoproteins in patients with hyperbetalipoproteinemia]L Zanaboni, D Sommariva, D Bonfiglioli, et al.
Lancet (London, England)|December 27, 1975
Letter: Diuretic-induced oedemaG Norbiato, D Sommariva, R Gandini, et al.
Diabetes Care|September 4, 1998
Accuracy of calculated serum low-density lipoprotein cholesterol for the assessment of coronary heart disease risk in NIDDM patientsA Branchi, A Rovellini, A Torri, et al.
International Journal of Clinical Pharmacology and Therapeutics|June 1, 1995
Effects of bezafibrate and of 2 HMG-CoA reductase inhibitors on lipoprotein (a) level in hypercholesterolemic patientsA Branchi, A Rovellini, A M Fiorenza, et al.
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Recenti Progressi in Medicina|October 1, 1982
[The problem of atherogenesis. Relationship to intracellular metabolism of cholesterol]D Sommariva, D Bonfiglioli
International Journal of Clinical Pharmacology Research|January 1, 1995
Effect of bezafibrate on HDL with APO A-I and APO A-II and on HDL with APO A-I without APO A-II in hyperlipidaemic patientsA Branchi, A Rovellini, D Sommariva
Atherosclerosis|January 1, 1978
Low-fat diet versus low-carbohydrate diet in the treatment of type IV hyperlipoproteinaemiaD Sommariva, L Scotti, A Fasoli
International Journal of Clinical & Laboratory Research|February 24, 2001
Serum lipoprotein profile in patients with cancer. A comparison with non-cancer subjectsA M Fiorenza, A Branchi, D Sommariva
Drugs Under Experimental and Clinical Research|January 1, 1986
Effects of benfluorex on sterol biosynthesis in incubated human blood mononuclear cellsD Sommariva, F Blasi, R Cosentini, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|March 1, 1981
Effects of acetylsalicylic acid on plasma lipids and on post-heparin lipase activitiesD Sommariva, D Bonfiglioli, L Zanaboni, et al.
La Clinica Terapeutica|June 30, 1983
[Effects of nicotinic alcohol therapy on serum lipoproteins in patients with hyperbetalipoproteinemia]L Zanaboni, D Sommariva, D Bonfiglioli, et al.
Lancet (London, England)|December 27, 1975
Letter: Diuretic-induced oedemaG Norbiato, D Sommariva, R Gandini, et al.
Diabetes Care|September 4, 1998
Accuracy of calculated serum low-density lipoprotein cholesterol for the assessment of coronary heart disease risk in NIDDM patientsA Branchi, A Rovellini, A Torri, et al.
International Journal of Clinical Pharmacology and Therapeutics|June 1, 1995
Effects of bezafibrate and of 2 HMG-CoA reductase inhibitors on lipoprotein (a) level in hypercholesterolemic patientsA Branchi, A Rovellini, A M Fiorenza, et al.
Pageof 5